← Back
Data updated: Mar 10, 2026
AVERITAS
OncologyNeurology
AVERITAS is a pharmaceutical company focused on Oncology, Neurology. Key products include MOVANTIK.
2009
Since
2
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 50%
1 drugs
Neurology 50%
1 drugs
Pipeline Strength Pro
Loading...